TETRA BIO-PHARMA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.83% |
| Sales 2020 | - | Sales 2021 | - | Capitalization | 88.81M 7.09B |
|---|---|---|---|---|---|
| Net income 2020 | -26M -2.07B | Net income 2021 | -52M -4.15B | EV / Sales 2020 | - |
| Net cash position 2020 | 501K 39.95M | Net cash position 2021 | 1.77M 142M | EV / Sales 2021 | - |
| P/E ratio 2020 |
-1.86
x | P/E ratio 2021 |
-1.7
x | Employees | 33 |
| Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 99.01% |
More Fundamentals
* Assessed data
More press releases
Current year
0.00
0.00
1 year
0.000.03
3 years
0.000.35
5 years
0.000.60
10 years
0.001.41
| Managers | Title | Age | Since |
|---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 31/05/16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 31/05/16 |
Catherine Auld
BRD | Director/Board Member | - | 27/05/21 |
H. Norton
CHM | Chairman | 63 | 16/09/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/05/24 | 0.000001 | 0.00% | 46,700 |
| 03/05/24 | 0.000001 | 0.00% | 20,000 |
Delayed Quote OTC Markets, May 09, 2024 at 04:09 pm
More quotes
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -99.83% | 515 | |
| +43.25% | 6.3B | |
| -15.08% | 4.53B | |
| -6.70% | 3.29B | |
| +5.47% | 3.2B | |
| +0.76% | 2.63B | |
| +47.75% | 1.97B | |
| -5.08% | 1.74B | |
| +2.05% | 1.69B | |
| -7.08% | 1.64B |
- Stock Market
- Equities
- TBPMQ Stock
